BioSymetrics
Phenomics-driven AI company translating disease biology into precision medicine discoveries.
About
Technology stack
detected 2026-06-24No comments yet. Be the first to share your take.
What does BioSymetrics do?
BioSymetrics is a phenomics-driven company that leverages AI and in vivo validation to translate complex human disease biology into discoveries. Their platform connects disease phenotype and genotype data, using machine learning predictions to identify higher-confidence targets and precision medicines.
How much funding has BioSymetrics raised?
BioSymetrics has raised a total of $7M in funding. The most recent round on record is Seed.
Where is BioSymetrics headquartered?
BioSymetrics is headquartered in Boston, United States.
When was BioSymetrics founded?
BioSymetrics was founded in 2017.
What industry does BioSymetrics operate in?
BioSymetrics operates in Biotech, HealthTech, Drug Discovery, Genomics, AI-Driven Drug Discovery, Precision Medicine.
How many employees does BioSymetrics have?
BioSymetrics has approximately 14 people on record.